Toward Tailored Chemo
Mapping drug responses and tumor genetics could lead to biomarkers for chemotherapy efficacy
A group at UCSF is bringing precision medicine to chemotherapies, with a predictive model for drug responses based on single gene deletions.
Despite advances in immuno-oncology and targeted therapies, nearly 95% of cancer patients receive chemotherapy as “the backbone of their cancer care,” according to Sourav Bandyopadhyay, an assistant professor of bioengineering and therapeutic
